Background: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity in the elderly population. COPD leads to a reduced health-related quality of life (HRQL), but the factors which contribute to this are not well understood. A better understanding of the factors which determine HRQL should lead to an improved care for such patients. Objectives: The purpose of this study was to investigate possible age-related differences in HRQL in a population of patients with a similar severity of obstruction. Methods: A total of 180 consecutive COPD patients were enrolled into the study. We analyzed spirometric data, BODE index and its components, and comorbidities were assessed by the Charlson index. HRQL was assessed by the Clinical COPD Questionnaire (CCQ) and St. George's Respiratory Questionnaire (SGRQ). Results: The cohort consisted of 93 ‘younger' patients (mean age 54.8 ± 3.1 years) and 87 older patients (mean age 73.1 ± 5.5 years). Patients in both groups had a similar severity of obstruction: FEV1 (% from predicted) was 39.9 ± 13.2% in the elderly group compared to 41.7 ± 11.7% in the younger group (p > 0.05). The forward stepwise regression analysis shows that the BODE index, the Charlson index, and the rate of exacerbations are important predictors of deterioration of HRQL in elderly COPD patients, which explains 29% of the total SGRQ score. In the younger COPD patients, the coefficient of determination R2 was 0.27, but the predictors were the BODE index and the rate of exacerbations. Conclusions: The BODE index, the Charlson index, and the rate of exacerbations were found to be the major determinants of HRQL in elderly COPD patients, while in younger COPD patients, the BODE index and the rate of exacerbations were influential factors.

Keywords:
St. George’s Respiratory Questionnaire, Clinical COPD Questionnaire, Quality of life, Chronic obstructive pulmonary disease
1.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. http://www.goldcopd.org/ (accessed December 2013).
2.
Corlateanu A, Montanari G, Mathioudakis A, Botnaru V, Siafakas N: Management of stable COPD: an update. Curr Respir Med Rev 2013;9:352-359.
3.
Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
4.
van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:1-13.
5.
Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M; EVOCA study group: Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract 2008;62:585-592.
6.
Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, et al: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59:387-395.
7.
Katsura H, Yamada K, Kida K: Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2003;51:1131-1135.
8.
Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, et al: Validation and clinical interpretation of the St. George's Respiratory Questionnaire among COPD patients, China. Int J Tuberc Lung Dis 2009;13:181-189.
9.
Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, Espana PP, et al: Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009;103:1201-1208.
10.
Oga T, Tsukino M, Hajiro T, Ikeda A, Koyama H, Mishima M, et al: Multidimensional analyses of long-term clinical courses of asthma and chronic obstructive pulmonary disease. Allergol Int 2010;59:257-265.
11.
Peruzza S, Sergi G, Vianello A, Pisent C, Tiozzo F, Manzan A, et al: Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med 2003;97:612-617.
12.
Ohayon MM: Chronic obstructive pulmonary disease and its association with sleep and mental disorders in the general population. J Psychiatr Res 2014;54:79-84.
13.
Lahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al: Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J 2015;36:1754-1761.
14.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. http://www.goldcopd.org/ (accessed February 2015).
15.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
16.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
17.
Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
18.
Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M: Reviewing the definition of ‘elderly'. Geriatr Gerontol Int 2006;6:149-158.
19.
Guyatt GH, Townsend M, Berman LB, Pugsley SO: Quality of life in patients with chronic airflow limitation. Br J Dis Chest 1987;81:45-54.
20.
Woods RT, Britton PG: Clinical Psychology with the Elderly. London, Croom Helm, 1985.
21.
Peruzza S, Sergi G, Vianello A, Pisent C, Tiozzo F, Manzan A, Coin A, Inelmen EM, Enzi G: Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med 2003;97:612-617.
22.
Renwick DS, Connolly MJ: Impact of obstructive airways disease on quality of life in older adults. Thorax 1996;51:520-525.
23.
Martinez CH, Diaz AA, Parulekar AD, Rennard SI, Kanner RE, Hansel NN, et al: Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS Cohorts. Chest 2016;149:927-935.
24.
Ringbaek T, Martinez G, Lange P: A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012;9:12-15.
25.
Ong KC, Lu SJ, Soh CS: Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis 2006;1:91-96.
26.
Sarkar SK, Basuthakur S, Das SK, Das A, Das S, Choudhury S, Datta S: Evaluation of correlation of BODE index with health-related quality of life among patients with stable COPD attending a tertiary care hospital. Lung India 2015;32:24-28.
27.
Nonato NL, Diaz O, Nascimento OA, Dreyse J, Jardim JR, Lisboa C: Behavior of quality of life (SGRQ) in COPD patients according to BODE scores. Arch Bronconeumol 2015;51:315-321.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.